Health X Platform Ltd
₹ 278
-1.63%
01 Oct
1:22 p.m.
About
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Key Points
- Market Cap ₹ 884 Cr.
- Current Price ₹ 278
- High / Low ₹ 375 / 252
- Stock P/E
- Book Value ₹ 85.2
- Dividend Yield 0.00 %
- ROCE -0.30 %
- ROE -0.33 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.35 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.31% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.29 | 2.10 | 0.98 | 1.43 | 2.47 | 0.31 | 0.28 | 0.19 | 0.25 | 0.45 | 0.44 | 0.40 | 0.36 | |
| 2.00 | 2.00 | 1.77 | 1.90 | 1.88 | 1.33 | 0.90 | 1.04 | 1.41 | 1.93 | 1.79 | 1.47 | 1.76 | |
| Operating Profit | 0.29 | 0.10 | -0.79 | -0.47 | 0.59 | -1.02 | -0.62 | -0.85 | -1.16 | -1.48 | -1.35 | -1.07 | -1.40 |
| OPM % | 12.66% | 4.76% | -80.61% | -32.87% | 23.89% | -329.03% | -221.43% | -447.37% | -464.00% | -328.89% | -306.82% | -267.50% | -388.89% |
| 0.16 | -2.26 | -1.34 | 14.00 | 0.22 | 1.87 | 0.68 | 0.72 | 2.00 | 0.73 | 0.76 | 0.30 | 0.13 | |
| Interest | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.08 | 0.00 |
| Depreciation | 0.41 | 0.34 | 0.27 | 0.23 | 0.21 | 0.18 | 0.17 | 0.18 | 0.16 | 0.10 | 0.10 | 0.10 | 0.08 |
| Profit before tax | 0.02 | -2.52 | -2.43 | 13.28 | 0.58 | 0.64 | -0.14 | -0.34 | 0.65 | -0.89 | -0.72 | -0.95 | -1.35 |
| Tax % | -5,200.00% | -17.86% | -0.00% | 14.83% | 39.66% | -0.00% | -0.00% | 14.71% | -0.00% | -0.00% | -0.00% | -0.00% | |
| 1.05 | -2.07 | -2.44 | 11.32 | 0.36 | 0.64 | -0.14 | -0.39 | 0.65 | -0.89 | -0.71 | -0.95 | -1.35 | |
| EPS in Rs | 0.33 | -0.65 | -0.77 | 3.56 | 0.11 | 0.20 | -0.04 | -0.12 | 0.20 | -0.28 | -0.22 | -0.30 | -0.43 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | 7% |
| 3 Years: | 17% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -20% |
| TTM: | -125% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 0% |
| 3 Years: | 2% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 | 31.81 |
| Reserves | 194.15 | 192.08 | 189.64 | 240.01 | 240.96 | 241.59 | 241.44 | 241.00 | 241.61 | 240.72 | 239.99 | 239.05 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 0.64 | 0.36 | 1.81 | 0.79 | 6.03 | 0.56 | 0.27 | 0.30 | 0.43 | 0.40 | 0.36 | 0.16 | |
| Total Liabilities | 226.60 | 224.25 | 223.26 | 272.61 | 278.80 | 273.96 | 273.52 | 273.11 | 273.85 | 272.93 | 272.16 | 271.02 |
| 3.83 | 4.47 | 4.19 | 4.17 | 3.95 | 3.40 | 3.24 | 3.12 | 2.13 | 2.02 | 1.94 | 1.76 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 219.66 | 217.29 | 217.69 | 259.11 | 274.15 | 269.56 | 269.43 | 264.98 | 265.60 | 264.87 | 264.64 | 264.66 |
| 3.11 | 2.49 | 1.38 | 9.33 | 0.70 | 1.00 | 0.85 | 5.01 | 6.12 | 6.04 | 5.58 | 4.60 | |
| Total Assets | 226.60 | 224.25 | 223.26 | 272.61 | 278.80 | 273.96 | 273.52 | 273.11 | 273.85 | 272.93 | 272.16 | 271.02 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.06 | -0.01 | 1.27 | -9.20 | 3.61 | -0.83 | -0.51 | -0.52 | -0.63 | -1.21 | -5.51 | 0.04 | |
| 3.94 | 0.23 | -1.00 | 12.34 | -7.62 | 0.97 | 0.47 | 0.54 | 0.64 | 1.09 | 5.45 | -0.01 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Net Cash Flow | -0.12 | 0.22 | 0.28 | 3.14 | -4.01 | 0.14 | -0.04 | 0.02 | 0.02 | -0.11 | -0.06 | 0.03 |
| Free Cash Flow | -4.12 | -0.05 | 1.27 | -9.22 | 3.64 | -0.19 | -0.52 | -0.57 | 1.46 | -1.21 | -5.51 | 0.04 |
| CFO/OP | -1,321% | 180% | -66% | 1,560% | 651% | 75% | 76% | 61% | 54% | 82% | 408% | -4% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6.38 | -0.00 | 14.90 | 206.75 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 6.38 | -0.00 | 14.90 | 206.75 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Working Capital Days | -65.35 | -38.24 | -610.82 | 1,079.69 | -799.45 | 259.03 | 521.43 | 8,663.95 | 7,986.20 | 4,485.44 | 730.00 | 593.12 |
| ROCE % | 0.02% | -0.06% | -0.48% | -0.25% | 0.15% | -0.23% | -0.04% | -0.12% | -0.21% | -0.31% | -0.26% | -0.30% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of employees count |
|
|||||||||
| Retailer Shakti (B2B) revenue as % of healthcare network revenue % |
||||||||||
| Number of retail pharmacies served (Retailer Shakti B2B network) count |
||||||||||
| Number of SKUs / products available count |
||||||||||
| Market share in West Bengal (pharma distribution) % |
||||||||||
| Number of vendors / pharma companies count |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Disclosure Of Voting Results Of The 37Th AGM Of The Company As per Regulation 44 Of The SEBI (LODR) Reg, 2015
- 37th AGM voting results disclosed; all seven resolutions passed on 28 September 2026.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 37th AGM resolutions passed on 28 Sep 2026, including borrowing, security, loans and director reappointments.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Health X Platform held its 37th AGM on 28 September 2026; shareholders considered financials, director appointments and borrowing approvals.
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication regarding Notice of 37th Annual General Meeting and e-voting information.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from nse
-
Annual Report 2013
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
Jun 2026PPT
-
Feb 2026Transcript PPT
-
Feb 2026PPT
-
Nov 2025Transcript PPT
-
Aug 2025PPT
-
Jun 2025Transcript PPT
-
Feb 2025PPT
-
Nov 2024Transcript PPT
-
Oct 2024PPT
-
Jun 2024PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023PPT
-
Mar 2023PPT
-
Feb 2023PPT
-
Nov 2022PPT
-
Sep 2022PPT
-
Jun 2022PPT
-
Mar 2022PPT
-
Dec 2021PPT
-
Nov 2021PPT
-
Nov 2021PPT
-
Aug 2021PPT
-
Jun 2021PPT
-
Feb 2021PPT
-
Nov 2020PPT
-
Aug 2018PPT
-
Feb 2018PPT
-
Nov 2017PPT
Business Overview:[1][2][3]
SSVL, a Core Investment Company (CIC), operates through multiple subsidiaries and offers a digital platform for pharmacy, wellness, and diagnostics, serving both B2B and B2C segments with person-centric healthcare solutions.